Antipodes Partners’s Equifax EFX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-219,159
Closed -$26.2M 35
2020
Q1
$26.2M Sell
219,159
-100,244
-31% -$14.6M 1.37% 25
2019
Q4
$44.8M Sell
319,403
-151,030
-32% -$20.9M 2.02% 22
2019
Q3
$66.2M Sell
470,433
-234,621
-33% -$33.1M 3.16% 16
2019
Q2
$95.4M Buy
705,054
+175,789
+33% +$22M 4.38% 12
2019
Q1
$62.7M Buy
529,265
+8,367
+2% +$893K 3.1% 17
2018
Q4
$48.5M Buy
+520,898
New +$55.4M 2.4% 19

Other funds holding EFX

Antipodes Partners's EFX Position: Q2 2020 in Review

Antipodes Partners sold out of Equifax (EFX) in Q2 2020, closing a stake of 219,159 shares — an estimated $26.2M sold.

Antipodes Partners first reported a position in EFX in Q4 2018 and held it in 6 quarters. The position peaked at $95.4M in Q2 2019. 525 funds tracked by Wall St. Rank hold EFX as of Q2 2020.

  • Antipodes Partners reported no remaining Equifax position as of Q2 2020 after selling out during the quarter.
  • Antipodes Partners sold 219,159 Equifax shares in Q2 2020, an estimated $26.2M.
  • Antipodes Partners first reported a position in Equifax in Q4 2018 and held it in 6 quarters.
  • Antipodes Partners's Equifax position peaked at $95.4M in Q2 2019.
  • 525 funds tracked by Wall St. Rank held Equifax as of Q2 2020.

Based on Antipodes Partners's 13F filing for Q2 2020, filed 30 Jul 2020.